Recombinant Human Microsomal glutathione S-transferase 2 (MGST2)

What is Microsomal Glutathione S-transferase 2 (MGST2)?

MGST2 is a 17 kDa trimeric integral membrane protein that belongs to the MAPEG (membrane-associated proteins in eicosanoid and glutathione metabolism) protein family. It is localized to the nuclear and endoplasmic reticulum membranes, similar to other MAPEG members. MGST2 plays dual roles in cellular biochemistry, participating in both the detoxification of xenobiotics and the generation of pro-inflammatory compounds. As an integral membrane protein, it has structural and functional similarities with other MAPEG members, particularly leukotriene C4 synthase (LTC4S), though they exhibit distinct catalytic efficiencies .

How does MGST2 relate to other MAPEG family proteins?

The mammalian MAPEG family comprises six proteins: MGST1, MGST2, MGST3, LTC4S, five-lipoxygenase activating protein (FLAP), and microsomal prostaglandin E synthase (mPGES1). These proteins share 20-40% sequence similarity and have related structural features. Unlike FLAP, which has no described catalytic activity, the other five MAPEG members appear to share a common catalytic mechanism that involves binding and activation of glutathione (GSH) to form a thiolate, which is essential for their catalytic function .

MGST2 is particularly interesting because it shows functional overlap with LTC4S, though with distinct efficiency profiles. While MGST2 can catalyze the conversion of LTA4 to LTC4, it does so with approximately 48 times lower efficiency than LTC4S, with catalytic efficiencies (kcat/KM) of 1.8 × 104 M-1s-1 and 8.7 × 105 M-1s-1, respectively .

What is the cellular localization and tissue distribution of MGST2?

MGST2 is primarily localized to the nuclear and endoplasmic reticulum membranes as an integral membrane protein. Regarding tissue distribution, MGST2 mRNA has been detected across a wide range of human tissues. Notably, MGST2 shows high expression levels in human liver and endothelial cells, while lower mRNA levels are observed in lung cells .

This distribution pattern is functionally significant, as research has demonstrated that MGST2, rather than LTC4S, is responsible for LTC4 production in human umbilical vein endothelial cells. This finding suggests a tissue-specific role for MGST2 in LTC4 biosynthesis, particularly in endothelial cells which may lack significant LTC4S expression .

What are the main functions of MGST2 in human cells?

MGST2 performs several key functions in human cells:

• LTC4 biosynthesis: MGST2 catalyzes the conjugation of glutathione with LTA4 to form LTC4, a pro-inflammatory mediator involved in various inflammatory conditions. This function appears particularly important in cells with low LTC4S expression .

• Glutathione transferase activity: MGST2 demonstrates significant GST activity toward various electrophilic substrates, most notably 1-chloro-2,4-dinitrobenzene (CDNB), with a catalytic efficiency (kcat/KM) of 7.2 × 104 M-1s-1 .

• Glutathione-dependent peroxidase activity: MGST2 efficiently reduces lipid hydroperoxides (including 5-HpETE, 15-HpETE, 13-HpODE, and 13-HpOTrE) with catalytic efficiencies ranging from 0.6 × 104 to 1.8 × 104 M-1s-1 .

• Metabolism of products from lipid peroxidation: MGST2 shows activity toward 4-hydroxynonenal (4-HNE), a toxic byproduct of lipid peroxidation, suggesting a role in cellular defense against oxidative stress .

What are the optimal systems for expressing recombinant human MGST2?

The research indicates that Pichia pastoris (P. pastoris) provides an effective expression system for recombinant human MGST2. This represents a significant methodological advancement, as the article states: "In this study, we have, for the first time, overexpressed and purified the recombinant human membrane protein MGST2 using P. pastoris."

Prior to this innovation, studies had utilized membrane fractions of microsomes from Sf9 cells expressing MGST2. The P. pastoris system appears to offer advantages for producing purified MGST2 suitable for detailed biochemical characterization, including steady-state and pre-steady-state kinetic analyses. When selecting an expression system for MGST2, researchers should consider the protein's membrane-bound nature and the need to maintain proper folding and enzymatic activity .

What purification protocols yield the highest purity and activity of MGST2?

While the search results don't provide explicit details of the complete purification protocol, they indicate that the researchers successfully purified MGST2 expressed in P. pastoris, as evidenced by Figure 1 in the original article . For membrane proteins like MGST2, purification typically involves:

• Cell disruption under conditions that preserve protein structure and activity

• Membrane fraction isolation through differential centrifugation

• Solubilization using appropriate detergents that maintain enzyme activity

• Chromatographic purification steps, which may include affinity chromatography if the protein contains an affinity tag

The research demonstrates that the purified MGST2 maintained enzymatic activity toward multiple substrates, including LTA4, CDNB, and various lipid hydroperoxides, indicating that the purification protocol preserved the protein's functional integrity .

What are the key challenges in expressing and purifying functional MGST2?

As a trimeric integral membrane protein, MGST2 presents several challenges for expression and purification:

• Membrane protein expression: Overexpression of membrane proteins often faces obstacles including protein misfolding, aggregation, and cytotoxicity to the host cells.

• Maintaining quaternary structure: As a trimeric protein, maintaining MGST2's native oligomeric state during purification is critical for its function. The research indicates that MGST2 forms a functional trimer with specific stoichiometry in GSH binding (1:3 GS-:MGST2 subunit ratio) .

• Preserving catalytic activity: The purification process must carefully preserve the protein's ability to activate GSH and maintain catalysis. The research confirms that purified MGST2 retained the ability to lower the pKa of GSH, forming a thiolate anion essential for catalysis .

• Handling of detergents: The use of appropriate detergents at concentrations that solubilize the protein while maintaining its structure and function presents a significant challenge in membrane protein purification.

How does the P. pastoris expression system compare to other systems for MGST2 production?

The research highlights P. pastoris as a successful expression system for MGST2, representing an improvement over previous methods. Earlier studies utilized Sf9 cells for MGST2 expression but worked with membrane fractions rather than purified protein .

P. pastoris offers several advantages for membrane protein expression:

• High expression levels due to strong promoters (typically alcohol oxidase promoter)

• Post-translational modifications similar to mammalian cells

• Growth to high cell densities, improving protein yield

• Proper protein folding and membrane insertion capabilities

The research indicates that the P. pastoris system enabled, for the first time, the production of purified recombinant human MGST2 suitable for detailed biochemical and kinetic studies. This advancement allowed for direct determination of kinetic parameters and mechanistic studies that weren't possible with membrane fraction preparations .

What substrates does MGST2 act upon, and with what efficiency?

MGST2 demonstrates activity toward a diverse range of substrates, which can be categorized into several groups:

Epoxides:

• LTA4: Specific activity of 1.23 ± 0.14 μmol min-1 mg-1

• EPNP: <1.25 μmol min-1 mg-1

Lipid hydroperoxides:

• 5-HpETE: 0.25 ± 0.00 μmol min-1 mg-1

• 15-HpETE: 0.21 ± 0.00 μmol min-1 mg-1

• 13-HpODE: 0.20 ± 0.00 μmol min-1 mg-1

• 13-HpOTrE: 0.16 ± 0.00 μmol min-1 mg-1

Products from lipid peroxidation:

• 4-HNE: 0.91 ± 0.10 μmol min-1 mg-1

Electrophilic substrates:

• CDNB: 37.50 ± 1.50 μmol min-1 mg-1

• CNBAL: 2.55 ± 0.17 μmol min-1 mg-1

• CNAP: 0.43 ± 0.05 μmol min-1 mg-1

• CNBAM: 0.15 ± 0.02 μmol min-1 mg-1

The highest activity was observed with CDNB, a classic GST substrate, while significant activity was also observed with LTA4 and 4-HNE. The detailed kinetic parameters for various substrates are provided in the following table:

How does MGST2's catalytic efficiency compare to LTC4S in producing LTC4?

MGST2 is significantly less efficient than LTC4S in producing LTC4, as demonstrated by their respective catalytic efficiencies:

• MGST2: kcat/KM = 1.8 × 104 M-1 s-1

• LTC4S: kcat/KM = 8.7 × 105 M-1 s-1

A direct comparison of LTC4 production by various enzymes shows:

While MGST2's efficiency is lower than that of LTC4S, it is substantially higher than cytosolic GSTs and MGST1, suggesting a potential physiological role in LTC4 formation, particularly in cells with low LTC4S expression .

What is MGST2's glutathione-dependent peroxidase activity profile?

MGST2 demonstrates significant glutathione-dependent peroxidase activity toward various lipid hydroperoxides. The kinetic parameters for this activity are:

The KM values for these hydroperoxides range from 5 to 20 μM, which is comparable to the values observed for GSH-dependent peroxide reducing enzymes like hGSTA1-1 (KM of 5 μM). This suggests that MGST2 has a high affinity for lipid hydroperoxides and may efficiently reduce them at physiologically relevant concentrations .

The peroxidase activity of MGST2 may play an important role in regulating arachidonic acid metabolism and the formation of lipid mediators. Both 5-lipoxygenase and cyclooxygenase enzymes require a saturating "peroxide tone" (concentration of hydroperoxides) for catalysis, and MGST2's efficient peroxidase activity suggests it may indirectly regulate these pathways .

How is MGST2 activity measured in the laboratory?

Several methods are employed to measure different aspects of MGST2 activity:

1. LTC4 production:

• HPLC with UV detection at 280 nm can be used to measure LTC4 formation when MGST2 is incubated with LTA4 and GSH .

2. GST activity with CDNB:

• Spectrophotometric assays measuring the increase in absorbance at 340 nm as GSH conjugates with CDNB can quantify GST activity .

3. Peroxidase activity:

• The reduction of lipid hydroperoxides can be measured through coupled enzyme assays or by monitoring substrate consumption .

4. Thiolate anion formation:

• UV difference spectroscopy monitoring the absorbance increase at 239 nm (ε = 5000 M-1 cm-1) can detect GSH thiolate anion formation .

• Stopped-flow measurements can determine the kinetics of thiolate formation and dissociation .

5. GSH binding and release:

• Stopped-flow measurements at 239 nm can be used to determine the kinetics of GSH binding and GS- release .

These methodologies provide complementary information about MGST2's catalytic mechanism and substrate specificity, enabling comprehensive characterization of the enzyme's biochemical properties.

What is the catalytic mechanism of MGST2?

MGST2 follows a two-step catalytic mechanism that is common among MAPEG family proteins:

• GSH activation: The first step involves binding GSH and lowering its pKa to form a thiolate anion (GS-). This activated thiolate is then poised for nucleophilic attack on electrophilic substrates .

• Nucleophilic attack: The activated thiolate anion performs a nucleophilic attack on the electrophilic substrate, forming a conjugate product. For LTA4, this results in LTC4 formation; for CDNB, it leads to a GS-DNB conjugate .

For reactions with electrophilic substrates like CDNB and its derivatives, MGST2 displays a linear relationship when the logarithm of the rate constant is plotted against the Hammet substituent constant (σ-). The slope (ρ) of this relationship for MGST2 is 2.9 for log kcat, similar to the slope of 2.8 for the nonenzymatic rate. This suggests that chemical reactivity substantially contributes to the enzyme's catalytic efficiency .

For peroxidase activity, the mechanism likely involves the nucleophilic attack of the thiolate on the peroxide bond, resulting in the reduction of the hydroperoxide to the corresponding alcohol.

How does MGST2 activate glutathione to form a thiolate anion?

MGST2 activates glutathione by lowering its pKa from approximately 8-9 in solution to about 6.3 when bound to the enzyme. This activation is evidenced by an increase in absorbance at 239 nm in UV difference spectra, characteristic of thiolate anion formation .

The enzyme-catalyzed activation follows a two-step mechanism:

• Rapid equilibrium formation of an initial enzyme-GSH complex (KD GSH = 4.3 ± 0.6 mM)

• Conversion of bound GSH to the thiolate anion (k2 = 41.1 ± 1.2 s-1)

This activation mechanism is crucial for MGST2's catalytic function, as the thiolate anion serves as the nucleophile in subsequent reactions with electrophilic substrates. The ability to lower GSH's pKa appears to be a common feature among MAPEG proteins, facilitating their diverse catalytic activities .

What is the stoichiometry of GSH binding to MGST2?

MGST2 demonstrates an interesting stoichiometry in its interaction with GSH. Despite being a trimeric protein with three potential active sites, the amplitude of the absorbance signal at 239 nm (corresponding to thiolate anion formation) suggests a GS-:MGST2 subunit stoichiometry of 1:3 .

This indicates that only one of the three active sites in the MGST2 trimer appears to be catalytically competent for thiolate formation at any given time. This finding has important implications for understanding MGST2's catalytic mechanism and efficiency. It suggests that either:

• Only one subunit in the trimer is catalytically active

• There is negative cooperativity, where binding of GSH to one subunit prevents binding to the others

• There are conformational constraints that limit simultaneous catalysis at all three active sites

This 1:3 stoichiometry contrasts with some other trimeric enzymes where all three subunits can be simultaneously active, and may represent an important regulatory mechanism for MGST2 function.

What kinetic parameters characterize MGST2's interaction with GSH?

The interaction between MGST2 and GSH is characterized by several key kinetic parameters:

These parameters reveal important insights about MGST2's interaction with GSH:

• The initial binding of GSH is relatively weak (KD GSH = 4.3 mM), suggesting that high concentrations of GSH may be required for efficient catalysis.

• The formation of the thiolate anion (k2 = 41.1 s-1) is much faster than its dissociation (k-2 = 2.0 s-1), favoring the activated state.

• The thiolate anion (GS-) binds much more tightly (KD GS- = 136 μM) than the protonated form, consistent with its role as the reactive species in catalysis .

When compared to related enzymes like MGST1 and LTC4S, MGST2 shows distinct kinetic properties that may contribute to its specific physiological functions.

What is the potential role of MGST2 in inflammatory processes?

MGST2 may play a significant role in inflammatory processes primarily through its ability to produce leukotriene C4 (LTC4), a potent pro-inflammatory mediator. While MGST2 is less efficient than LTC4S in LTC4 production (48 times lower efficiency), its activity is still substantial compared to other GSTs .

Importantly, research has shown that MGST2, rather than LTC4S, is responsible for LTC4 production in human umbilical vein endothelial cells. This suggests that MGST2 may be the primary enzyme responsible for LTC4 biosynthesis in cells with low LTC4S expression levels .

The specific activity of MGST2 for LTC4 production (1.23 μmol min-1 mg-1) is considerably higher than that of cytosolic GSTs (2-10 nmol min-1 mg-1) and MGST1 (0.2 nmol min-1 mg-1), further supporting its potential physiological role in leukotriene biosynthesis and inflammatory signaling .

How might MGST2 regulate arachidonic acid metabolism?

MGST2 may regulate arachidonic acid metabolism through two main mechanisms:

• Direct contribution to leukotriene biosynthesis: By catalyzing the conversion of LTA4 to LTC4, MGST2 directly participates in the leukotriene branch of arachidonic acid metabolism, particularly in cells with low LTC4S expression .

• Indirect regulation through peroxidase activity: MGST2's efficient peroxidase activity toward lipid hydroperoxides may indirectly regulate arachidonic acid metabolism. Both 5-lipoxygenase and cyclooxygenase enzymes, which are key in producing leukotrienes and prostaglandins, require a saturating "peroxide tone" for catalysis. By modulating hydroperoxide levels, MGST2 may influence the activity of these enzymes and consequently affect the production of various eicosanoids .

The low KM values (5-20 μM) for lipid hydroperoxides suggest that MGST2 can effectively reduce these compounds at physiologically relevant concentrations, potentially regulating the "peroxide tone" necessary for 5-lipoxygenase and cyclooxygenase activities .

What distinguishes MGST2 function from other GSTs in cellular contexts?

Several features distinguish MGST2 from other GSTs in cellular contexts:

• Membrane localization: Unlike cytosolic GSTs, MGST2 is an integral membrane protein localized to the nuclear and endoplasmic reticulum membranes, positioning it to interact with membrane-associated substrates and pathways .

• LTC4 synthesis: MGST2 has substantially higher LTC4 synthase activity than cytosolic GSTs and MGST1, though lower than specialized LTC4S. This intermediate activity level may be significant in cells with low LTC4S expression .

• Substrate profile: MGST2 shows high activity toward lipid hydroperoxides and products of lipid peroxidation (like 4-HNE), suggesting specialized roles in lipid metabolism and oxidative stress responses .

• Catalytic mechanism: The formation of a GSH thiolate anion with a 1:3 stoichiometry (one active site per trimer) distinguishes MGST2 from many other GSTs and may represent a unique regulatory mechanism .

• Tissue distribution: MGST2's high expression in endothelial cells and its role in endothelial LTC4 production differentiate it from other GSTs with different tissue expression patterns .

What are the implications of MGST2's peroxidase activity for cellular redox regulation?

MGST2's efficient peroxidase activity toward lipid hydroperoxides has several important implications for cellular redox regulation:

• Regulation of inflammatory signaling: By modulating hydroperoxide levels, MGST2 may influence the activity of 5-lipoxygenase and cyclooxygenase enzymes, which require hydroperoxides for catalysis. This could affect the production of various eicosanoids involved in inflammatory signaling .

• Protection against oxidative stress: MGST2's ability to reduce lipid hydroperoxides (5-HpETE, 15-HpETE, 13-HpODE, 13-HpOTrE) and detoxify 4-HNE suggests a protective role against oxidative damage to cellular membranes .

• Maintenance of redox homeostasis: The catalytic efficiency of MGST2 toward lipid hydroperoxides (kcat/KM ranging from 0.6 × 104 to 1.8 × 104 M-1 s-1) and its low KM values (5-20 μM) indicate that it could efficiently reduce these compounds at physiologically relevant concentrations, helping maintain redox homeostasis .

• Complement to other antioxidant systems: MGST2's peroxidase activity may complement other cellular antioxidant systems, such as glutathione peroxidases and peroxiredoxins, providing an additional layer of protection against oxidative stress, particularly for membrane-derived peroxides .

Research suggests that MGST2's peroxidase activity, similar to that observed for certain selenium-dependent GSH peroxidases, may indirectly regulate arachidonic acid metabolism and the formation of lipid mediators, with potential implications for inflammatory processes and cellular responses to oxidative stress .